Sharon Osbourne ‘Frustrated’ Over Ozempic Use: ‘These Weight Loss Drugs Have Wrecked Her Metabolism’
Sharon Osbourne attends the Los Angeles premiere of “The Bikeriders” on June 17. Recently, she discussed on the “Osbournes” podcast the time. Matt Winkelmeyer/Getty Images Entertainment
Sharon Osbourne is reportedly expressing deep frustration with the effects of using Ozempic for weight loss, claiming the drug has negatively impacted her metabolism. According to RadarOnline, the 72-year-old feels the weight loss medication has caused lasting damage.
“She thinks these ‘weight loss drugs have wrecked her metabolism, and there’s no going back for her,’ a source revealed. Osbourne is said to be struggling to regain weight, leaving her concerned about her overall health. “She simply can’t put the weight back on that she needs to regain a healthy look.
It just shows the dangers of these ‘quick fix’ cures,” the insider continued, adding that Sharon’s weight appears to be on an “irreversible downward spiral.” While Sharon has faced challenges with the aftereffects of Ozempic, her daughter Kelly Osbourne has had a different experience with the weight loss drug. Kelly previously spoke positively about Ozempic, describing it as “the miracle drug in the right hands” in an interview with PEOPLE magazine.
Kelly shared that prior to using the FDA-approved medication, she struggled with body insecurity, admitting, “I didn’t want to look at my body.” Her positive experience with the drug contrasts with her mother’s concerns, highlighting the varying effects the medication can have on different individuals.
Sharon’s situation brings attention to the potential risks associated with quick-fix solutions like Ozempic, which have gained popularity for their weight loss benefits. Experts and users alike continue to debate the drug’s long-term effects on metabolism and overall health.
As Sharon navigates the challenges of reversing the impact on her body, her story serves as a cautionary tale for those considering similar treatments. Meanwhile, Kelly’s experience reflects the complexity of individual responses to such medications, showing both the potential benefits and the risks involved.
With growing public interest in weight loss drugs like Ozempic, the Osbourne family’s contrasting experiences highlight the importance of informed decision-making and medical guidance when exploring such options
